Efficacy of dupilumab in patients with asthma stratified by a minimally important fractional exhaled nitric oxide reduction at week 2 of treatment

被引:0
|
作者
Pavord, I. [1 ]
Wechsler, M. [2 ]
Busse, W. W. [3 ]
Domingo, C. [4 ]
Xia, C.
Gall, R. [5 ]
Pandit-Abid, N. [6 ]
Jacob-Nara, J. A. [6 ]
Amr, R. [5 ]
Rowe, P. J. [6 ]
Deniz, Y. [5 ]
机构
[1] Univ Oxford, Oxford, England
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli, Barcelona, Spain
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, MA USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
000332
引用
收藏
页码:183 / 183
页数:1
相关论文
共 50 条
  • [31] Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
    Mohan, Anant
    Kavitha, V.
    Madan, Karan
    Hadda, Vijay
    Guleria, Randeep
    Khilnani, G. C.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review
    Pianigiani, Tommaso
    Alderighi, Lorenzo
    Meocci, Martina
    Messina, Maddalena
    Perea, Beatrice
    Luzzi, Simona
    Bergantini, Laura
    D'Alessandro, Miriana
    Refini, Rosa Metella
    Bargagli, Elena
    Cameli, Paolo
    ANTIOXIDANTS, 2023, 12 (02)
  • [33] Summary for Clinicians: Clinical Practice Guideline for the Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma
    Murphy, Ryan C.
    Zhang, Peng
    Tejwani, Vickram
    Khatri, Sumita B.
    Hallstrand, Teal S.
    Ruminjo, Joseph K.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (10) : 1627 - 1630
  • [34] Blood Eosinophil Count and Fractional Exhaled Nitric Oxide as a Combined Predictor of Treatment Response to Benralizumab for Patients with Severe, Eosinophilic Asthma
    Katial, R.
    Kreindler, J.
    Hirsch, I
    Newbold, P.
    Gil, Garcia E. G.
    PNEUMOLOGIE, 2021, 75 : S34 - S34
  • [35] REDUCTION IN EXHALED NITRIC OXIDE (FENO) WITH DUPILUMAB AFTER PRIOR RESISTANCE TO ANTI-TH-2 BIOLOGICALS
    Cohen, B.
    Eisenberg, R.
    Rubinstein, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S100 - S100
  • [36] Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide
    Tang, Wei
    Zhou, Jun
    Miao, Lili
    Shi, GuoCao
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (02): : 595 - 600
  • [37] Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma
    Sahal, Adeel
    Das, Joyutpal
    Mansur, Adel
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [38] Fractional exhaled nitric oxide levels as a predictor of long-term prognoses in patients with mild asthma
    Yamashita, Masahiro
    Shibanai, Mitsue
    Sekimura, Kenshi
    Nitanai, Hiroo
    Ogasawara, Masahito
    Kobayashi, Hitoshi
    Yamauchi, Kohei
    RESPIRATORY INVESTIGATION, 2016, 54 (03) : 139 - 147
  • [39] Association between fractional exhaled nitric oxide and therapeutic adherence to controller management in pediatric asthma patients
    Cleves, Daniela
    Vargas, Pedro
    Acuna-Cordero, Ranniery
    Aguilera-Otalvaro, Paula
    Camargo, Bethy
    Aristizabal-Duque, Ricardo
    Rodriguez-Martinez, Carlos E.
    PEDIATRIC PULMONOLOGY, 2024, 59 (01) : 121 - 128
  • [40] Re-evaluation of the diagnostic value of fractional exhaled nitric oxide & its impact in patients with asthma
    He, Lixiu
    Wei, Meihui
    Luo, Jian
    Du, Wen
    Zhang, Liangliang
    Zhang, Lanlan
    Liu, Chuntao
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (04) : 441 - 448